Please login to the form below

A Stellar Start to 2021 for Lucid Group

It’s been a stellar start to 2021 for Lucid Group, which has welcomed 38 new starters into the company since the beginning of the year. These include 15 Client Services colleagues, 14 medical writers, 5 scientific directors, 3 new people supporting our Finance and Legal central services teams and 1 new business leader.

Aside from the many new talent acquisitions made, Lucid has also been busy celebrating the successes from within its own teams with a total of 24 promotions. This included Sally Stringer being promoted to Managing Partner of the HealthCare21 team.

Sally commented, "I am thrilled to be taking the helm, to ensure the HealthCare21 team continues to inspire and invigorate our clients, maintain our values and drive positive transformation within healthcare."

Another two of these promotions were into new, exciting roles: Tanya Goodyear was appointed Director of Innovation and Technology and Cheryl Harrison Doyle was promoted to Global Asset Strategy Director. Before moving into her new role, Tanya was Managing Partner for Lucid’s medcomms team, Origins, and Cheryl previously held the position of Client Partnership Director.

Both of these new roles demonstrate Lucid’s ambition to build a global, industry-leading multi-capability healthcare communications company. It’s an extremely exciting time to be joining the organisation as it builds scale and develops new services for its clients. For example, as Global Asset Strategy Director, Cheryl will lead the identification and integration of key capabilities and programmes that go beyond medcomms to support clients in meeting their strategic priorities and improve health outcomes.

Cheryl commented, “I have been with Lucid Group now for more than 11 years and I am delighted and honoured to have the opportunity of pioneering a new capability within the organisation.  This role is fundamental to supporting our continued success, both within and beyond medical communications.  I look forward to the challenge and creating new opportunities that support our clients to meet their strategic goals.”

As a purpose-driven company, everything we do is underpinned by our passion and desire to transform the lives of those we touch, including our teams, clients, partners, our communities and for patients.

We are entering a new and exciting phase at Lucid Group. Our partnership with Intermediate Capital Group (ICG) will allow us to transform more lives than ever before. So, if you're looking to transform yours, join us – we're hiring!

Contact our talent acquisition managers Daniel Newbury or Lucinda Fowkes to discuss the great career opportunities we have to offer.

16th March 2021

Share

Tags

Company Details

Lucid Group Communications Limited

0345 0536671

Contact Website

Address:
First Floor, Jubilee House
Third Avenue
Globe Park
Marlow
Bucks
SL7 1EY
UK

Latest content on this profile

Listen, learn and lift off

Lucid Group Communications Limited
Launch excellence

Lucid Group Communications Limited
Meet The Lucid Group Talent Team
Meet our talent team, they're here to help and transform your career.We have some exciting roles at all levels in account management and medical writing.If you choose to take your career to the next level with us, you can be assured that you'll have a whole group of people here cheering you on.So, if you’re feeling stuck or unfulfilled in your current role and looking for a company that will provide the personal and career development you need, please check out our open roles here: https://bit.ly/3jhlhUNOr contact one of our talent acquisition managers for a chat:Ellen Field Assoc CIPDElaine DowneyJon TurnerDaniel Newbury
Lucid Group Communications Limited
Extraordinary lives: advancing change in rare diseases (Part 2)

Lucid Group Communications Limited
Extraordinary lives: advancing change in rare diseases (Part 2)
In support of Rare Disease Day, we're excited to launch part 2 of our video series; Extraordinary lives: advancing change in rare diseases.Why is raising awareness of rare diseases so important?Because 300 million people worldwide are living with a rare disease. This means that, collectively, the number of people living with a rare disease is equivalent to the population of the world's third-largest country (USA).While we have come a long way since the inception of Rare Disease Day, there's still plenty of work to do.Part 2 of this series focuses on important topics including the role of technology and the opportunities it presents for the rare disease community. The panel also hold captivating insights on how the pandemic has impacted the use of related digital technologies, the role of gene therapy, the major challenges and successes for pharma companies in supporting the rare disease community over the last 13 years, and much, much more.If you’d like to know more about the work we do in rare diseases or would like advice on any healthcare communication challenges please get in touch with Clare Reynolds on LinkedIn or by email: clare.reynolds@wearelucidgroup.comAbout Lucid GroupFounded in 2007, Lucid Group is a global multi-capability healthcare consultancy with core expertise in medical strategy, healthcare communications, creative and brand strategy, motion, digital and technology, behaviour change, metrics, and data analytics.  We partner with the pharma and biotech industry, delivering life-transforming value with connected capabilities to create pioneering solutions that change behaviour, improve clinical practice and advance health outcomes.  Transforming lives. Always.
Lucid Group Communications Limited
Extraordinary lives: advancing change in rare diseases (Part 1)

Lucid Group Communications Limited